nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00069	0.00069	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000676	0.000676	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000676	0.000676	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000672	0.000672	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000672	0.000672	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00067	0.00067	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000669	0.000669	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000658	0.000658	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000655	0.000655	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000647	0.000647	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000643	0.000643	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000641	0.000641	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000639	0.000639	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000634	0.000634	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000628	0.000628	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000628	0.000628	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000628	0.000628	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000625	0.000625	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000621	0.000621	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000618	0.000618	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000618	0.000618	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00061	0.00061	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00061	0.00061	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000608	0.000608	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000607	0.000607	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000605	0.000605	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000602	0.000602	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000601	0.000601	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000601	0.000601	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	0.000597	0.000597	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000595	0.000595	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000591	0.000591	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000588	0.000588	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000583	0.000583	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000576	0.000576	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000574	0.000574	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000572	0.000572	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00057	0.00057	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00057	0.00057	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000568	0.000568	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000567	0.000567	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000565	0.000565	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000564	0.000564	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	0.000562	0.000562	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000561	0.000561	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000561	0.000561	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000556	0.000556	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000549	0.000549	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000549	0.000549	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000549	0.000549	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000543	0.000543	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00053	0.00053	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000525	0.000525	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000525	0.000525	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000521	0.000521	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00052	0.00052	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000517	0.000517	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000514	0.000514	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000513	0.000513	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00051	0.00051	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00051	0.00051	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00051	0.00051	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000505	0.000505	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000499	0.000499	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000498	0.000498	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000498	0.000498	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000494	0.000494	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000493	0.000493	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000492	0.000492	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00049	0.00049	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000488	0.000488	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000485	0.000485	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000483	0.000483	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000482	0.000482	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000475	0.000475	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000474	0.000474	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000471	0.000471	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000469	0.000469	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000466	0.000466	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000466	0.000466	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000463	0.000463	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000463	0.000463	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000463	0.000463	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000461	0.000461	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000459	0.000459	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000458	0.000458	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000457	0.000457	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000457	0.000457	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000457	0.000457	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000451	0.000451	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00045	0.00045	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000449	0.000449	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000447	0.000447	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000445	0.000445	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000443	0.000443	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000438	0.000438	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000438	0.000438	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000434	0.000434	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000431	0.000431	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00043	0.00043	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000427	0.000427	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000425	0.000425	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000422	0.000422	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000421	0.000421	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00042	0.00042	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000418	0.000418	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000417	0.000417	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000416	0.000416	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000411	0.000411	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000409	0.000409	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000406	0.000406	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000403	0.000403	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.0004	0.0004	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000399	0.000399	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000399	0.000399	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000399	0.000399	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000392	0.000392	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000383	0.000383	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000383	0.000383	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000381	0.000381	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000379	0.000379	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000373	0.000373	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000373	0.000373	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000372	0.000372	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000371	0.000371	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000366	0.000366	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000364	0.000364	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000363	0.000363	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00036	0.00036	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00036	0.00036	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000359	0.000359	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000359	0.000359	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000356	0.000356	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000355	0.000355	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000351	0.000351	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00035	0.00035	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000346	0.000346	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00034	0.00034	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00034	0.00034	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000338	0.000338	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000337	0.000337	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000337	0.000337	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000335	0.000335	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000334	0.000334	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000333	0.000333	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000331	0.000331	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000331	0.000331	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000331	0.000331	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00033	0.00033	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000325	0.000325	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000323	0.000323	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000318	0.000318	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000313	0.000313	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000311	0.000311	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000308	0.000308	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000308	0.000308	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000308	0.000308	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000307	0.000307	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000304	0.000304	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000303	0.000303	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000303	0.000303	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000298	0.000298	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000297	0.000297	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000297	0.000297	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000294	0.000294	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000294	0.000294	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000292	0.000292	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000291	0.000291	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00029	0.00029	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000289	0.000289	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000286	0.000286	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000282	0.000282	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000277	0.000277	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000276	0.000276	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000274	0.000274	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000273	0.000273	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000273	0.000273	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00027	0.00027	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000265	0.000265	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000264	0.000264	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000263	0.000263	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000262	0.000262	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000259	0.000259	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000259	0.000259	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000255	0.000255	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000254	0.000254	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000254	0.000254	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	0.000252	0.000252	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00025	0.00025	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00025	0.00025	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	0.000248	0.000248	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000247	0.000247	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000246	0.000246	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000246	0.000246	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	0.000242	0.000242	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000242	0.000242	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000229	0.000229	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000226	0.000226	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000226	0.000226	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000226	0.000226	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	0.000218	0.000218	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	0.000216	0.000216	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000215	0.000215	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000214	0.000214	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000211	0.000211	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000211	0.000211	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00021	0.00021	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000208	0.000208	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000204	0.000204	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000203	0.000203	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	0.000202	0.000202	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000199	0.000199	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000199	0.000199	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	0.000197	0.000197	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000195	0.000195	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000191	0.000191	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000188	0.000188	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000187	0.000187	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000184	0.000184	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000182	0.000182	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000179	0.000179	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	0.000177	0.000177	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000175	0.000175	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000174	0.000174	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000174	0.000174	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000172	0.000172	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000171	0.000171	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000167	0.000167	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000159	0.000159	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000157	0.000157	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000155	0.000155	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00015	0.00015	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000148	0.000148	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000147	0.000147	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000144	0.000144	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000135	0.000135	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000128	0.000128	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000126	0.000126	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000124	0.000124	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000119	0.000119	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000118	0.000118	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	9.28e-05	9.28e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	8.67e-05	8.67e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	8.53e-05	8.53e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.58e-05	7.58e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.04e-05	7.04e-05	CbGpPWpGaD
